Stoke Therapeutics to Participate at Upcoming March Investor Conferences

Author's Avatar
Feb 27, 2023

Stoke+Therapeutics%2C+Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will be participating at the following upcoming investor conferences: